159 related articles for article (PubMed ID: 26616174)
21. D-Serine exposure resulted in gene expression changes indicative of activation of fibrogenic pathways and down-regulation of energy metabolism and oxidative stress response.
Soto A; DelRaso NJ; Schlager JJ; Chan VT
Toxicology; 2008 Jan; 243(1-2):177-92. PubMed ID: 18061331
[TBL] [Abstract][Full Text] [Related]
22. The biguanide metformin alters phosphoproteomic profiling in mouse brain.
Khang R; Park C; Shin JH
Neurosci Lett; 2014 Sep; 579():145-50. PubMed ID: 25067825
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of glioblastoma tumorspheres by combined treatment with 2-deoxyglucose and metformin.
Kim EH; Lee JH; Oh Y; Koh I; Shim JK; Park J; Choi J; Yun M; Jeon JY; Huh YM; Chang JH; Kim SH; Kim KS; Cheong JH; Kim P; Kang SG
Neuro Oncol; 2017 Feb; 19(2):197-207. PubMed ID: 27571886
[TBL] [Abstract][Full Text] [Related]
24. NLK functions to maintain proliferation and stemness of NSCLC and is a target of metformin.
Suwei D; Liang Z; Zhimin L; Ruilei L; Yingying Z; Zhen L; Chunlei G; Zhangchao L; Yuanbo X; Jinyan Y; Gaofeng L; Xin S
J Hematol Oncol; 2015 Oct; 8():120. PubMed ID: 26503334
[TBL] [Abstract][Full Text] [Related]
25. Metformin inhibits proliferation and growth hormone secretion of GH3 pituitary adenoma cells.
An J; Pei X; Zang Z; Zhou Z; Hu J; Zheng X; Zhang Y; He J; Duan L; Shen R; Zhang W; Zhu F; Li S; Yang H
Oncotarget; 2017 Jun; 8(23):37538-37549. PubMed ID: 28380462
[TBL] [Abstract][Full Text] [Related]
26. Metformin Targets Central Carbon Metabolism and Reveals Mitochondrial Requirements in Human Cancers.
Liu X; Romero IL; Litchfield LM; Lengyel E; Locasale JW
Cell Metab; 2016 Nov; 24(5):728-739. PubMed ID: 27746051
[TBL] [Abstract][Full Text] [Related]
27. Metformin-suppressed differentiation of human visceral preadipocytes: Involvement of microRNAs.
Fujita K; Iwama H; Oura K; Tadokoro T; Hirose K; Watanabe M; Sakamoto T; Katsura A; Mimura S; Nomura T; Tani J; Miyoshi H; Morishita A; Yoneyama H; Okano K; Suzuki Y; Himoto T; Masaki T
Int J Mol Med; 2016 Oct; 38(4):1135-40. PubMed ID: 27600587
[TBL] [Abstract][Full Text] [Related]
28. Metformin as an anti-cancer agent: actions and mechanisms targeting cancer stem cells.
Saini N; Yang X
Acta Biochim Biophys Sin (Shanghai); 2018 Feb; 50(2):133-143. PubMed ID: 29342230
[TBL] [Abstract][Full Text] [Related]
29. Metformin Induces Apoptosis and Downregulates Pyruvate Kinase M2 in Breast Cancer Cells Only When Grown in Nutrient-Poor Conditions.
Silvestri A; Palumbo F; Rasi I; Posca D; Pavlidou T; Paoluzi S; Castagnoli L; Cesareni G
PLoS One; 2015; 10(8):e0136250. PubMed ID: 26291325
[TBL] [Abstract][Full Text] [Related]
30. The phenomenon of acquired resistance to metformin in breast cancer cells: The interaction of growth pathways and estrogen receptor signaling.
Scherbakov AM; Sorokin DV; Tatarskiy VV; Prokhorov NS; Semina SE; Berstein LM; Krasil'nikov MA
IUBMB Life; 2016 Apr; 68(4):281-92. PubMed ID: 26892736
[TBL] [Abstract][Full Text] [Related]
31. Transcriptomic landscape profiling of metformin-treated healthy mice: Implication for potential hypertension risk when prophylactically used.
Meng Y; Xiang R; Yan H; Zhou Y; Hu Y; Yang J; Zhou Y; Cui Q
J Cell Mol Med; 2020 Jul; 24(14):8138-8150. PubMed ID: 32529766
[TBL] [Abstract][Full Text] [Related]
32. Activation of AMPK is neuroprotective in the oxidative stress by advanced glycosylation end products in human neural stem cells.
Lin CH; Cheng YC; Nicol CJ; Lin KH; Yen CH; Chiang MC
Exp Cell Res; 2017 Oct; 359(2):367-373. PubMed ID: 28821394
[TBL] [Abstract][Full Text] [Related]
33. A quantitative transcriptomic analysis of the physiological significance of mTOR signaling in goat fetal fibroblasts.
Fu Y; Zheng X; Jia X; Binderiya U; Wang Y; Bao W; Bao L; Zhao K; Fu Y; Hao H; Wang Z
BMC Genomics; 2016 Nov; 17(1):879. PubMed ID: 27821074
[TBL] [Abstract][Full Text] [Related]
34. Impact of 2-deoxy-D-glucose on the target metabolome profile of a human endometrial cancer cell line.
Urakami K; Zangiacomi V; Yamaguchi K; Kusuhara M
Biomed Res; 2013; 34(5):221-9. PubMed ID: 24190234
[TBL] [Abstract][Full Text] [Related]
35. Nutrients in Energy and One-Carbon Metabolism: Learning from Metformin Users.
Luciano-Mateo F; Hernández-Aguilera A; Cabre N; Camps J; Fernández-Arroyo S; Lopez-Miranda J; Menendez JA; Joven J
Nutrients; 2017 Feb; 9(2):. PubMed ID: 28208582
[TBL] [Abstract][Full Text] [Related]
36. Differences in p53 status significantly influence the cellular response and cell survival to 1,25-dihydroxyvitamin D3-metformin cotreatment in colorectal cancer cells.
Abu El Maaty MA; Strassburger W; Qaiser T; Dabiri Y; Wölfl S
Mol Carcinog; 2017 Nov; 56(11):2486-2498. PubMed ID: 28618116
[TBL] [Abstract][Full Text] [Related]
37. Metformin activation of AMPK suppresses AGE-induced inflammatory response in hNSCs.
Chung MM; Nicol CJ; Cheng YC; Lin KH; Chen YL; Pei D; Lin CH; Shih YN; Yen CH; Chen SJ; Huang RN; Chiang MC
Exp Cell Res; 2017 Mar; 352(1):75-83. PubMed ID: 28159472
[TBL] [Abstract][Full Text] [Related]
38. Effect of metformin on estrogen and progesterone receptor-positive (MCF-7) and triple-negative (MDA-MB-231) breast cancer cells.
Amaral I; Silva C; Correia-Branco A; Martel F
Biomed Pharmacother; 2018 Jun; 102():94-101. PubMed ID: 29550639
[TBL] [Abstract][Full Text] [Related]
39. Serum metabolomic profiling in acute alcoholic hepatitis identifies multiple dysregulated pathways.
Rachakonda V; Gabbert C; Raina A; Bell LN; Cooper S; Malik S; Behari J
PLoS One; 2014; 9(12):e113860. PubMed ID: 25461442
[TBL] [Abstract][Full Text] [Related]
40. Metformin Improves Diabetic Bone Health by Re-Balancing Catabolism and Nitrogen Disposal.
Li X; Guo Y; Yan W; Snyder MP; Li X
PLoS One; 2015; 10(12):e0146152. PubMed ID: 26716870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
